Follow
Siddhant Palekar
Siddhant Palekar
Product Development Scientist, Aprecia Pharmaceuticals
Verified email at stjohns.edu
Title
Cited by
Cited by
Year
Application of 3D printing technology and quality by design approach for development of age-appropriate pediatric formulation of baclofen
S Palekar, PK Nukala, SM Mishra, T Kipping, K Patel
International journal of pharmaceutics 556, 106-116, 2019
1662019
Abuse deterrent immediate release egg-shaped tablet (Egglets) using 3D printing technology: quality by design to optimize drug release and extraction
PK Nukala, S Palekar, M Patki, K Patel
Aaps Pharmscitech 20, 1-12, 2019
962019
Investigating the application of FDM 3D printing pattern in preparation of patient-tailored dosage forms
PK Nukala, S Palekar, N Solanki, Y Fu, M Patki, AA Shohatee, ...
Journal of 3D printing in medicine 3 (1), 23-37, 2019
542019
Process optimization of twin-screw melt granulation of fenofibrate using design of experiment (DoE)
HK Mamidi, S Palekar, PK Nukala, SM Mishra, M Patki, Y Fu, P Supner, ...
International Journal of Pharmaceutics 593, 120101, 2021
352021
Multi-dose oral abuse deterrent formulation of loperamide using hot melt extrusion
PK Nukala, S Palekar, M Patki, Y Fu, K Patel
International journal of pharmaceutics 569, 118629, 2019
282019
Self-injectable extended release formulation of Remdesivir (SelfExRem): A potential formulation alternative for COVID-19 treatment
M Patki, S Palekar, S Reznik, K Patel
International Journal of Pharmaceutics 597, 120329, 2021
162021
Nanocrystals for controlled delivery: state of the art and approved drug products
RS Kalhapure, S Palekar, K Patel, J Monpara
Expert opinion on drug delivery 19 (10), 1303-1316, 2022
152022
Aversion liquid-filled drug releasing capsule (3D-RECAL): A novel technology for the development of immediate release abuse deterrent formulations using a fused deposition …
S Palekar, PK Nukala, K Patel
International Journal of Pharmaceutics 621, 121804, 2022
122022
Abuse deterrent immediate release film technology (ADRIFT): A novel bilayer film technology for limiting intentional drug abuse
S Palekar, PK Nukala, R Vartak, K Patel
International Journal of Pharmaceutics 590, 119944, 2020
112020
Overdose and alcohol sensitive immediate release system (OASIS) for deterring accidental overdose or abuse of drugs
M Patki, S Palekar, PK Nukala, R Vartak, K Patel
Aaps Pharmscitech 22, 1-12, 2021
102021
Ibrutinib amorphous solid dispersions with enhanced dissolution at colonic pH for the localized treatment of colorectal cancer
H Patel, S Palekar, A Patel, K Patel
International Journal of Pharmaceutics 641, 123056, 2023
92023
Development of a safe pediatric liquisolid self-nanoemulsifying system of triclabendazole for the treatment of fascioliasis
S Daware, M Patki, A Saraswat, S Palekar, K Patel
International Journal of Pharmaceutics 626, 122163, 2022
82022
Tunable Drug Release from Fused Deposition Modelling (FDM) 3D-Printed Tablets Fabricated Using a Novel Extrudable Polymer
V Raje, S Palekar, S Banella, K Patel
Pharmaceutics 14 (10), 2192, 2022
72022
Corroborating various material-sparing techniques with hot melt extrusion for the preparation of triclabendazole amorphous solid dispersions
S Palekar, HK Mamidi, Y Guo, R Vartak, K Patel
International Journal of Pharmaceutics 640, 122989, 2023
42023
Tunable drug release from fused deposition modelling (FDM) 3D-printed tablets fabricated using a novel extrudable polymer. Pharmaceutics. 2022; 14: 2192. MDPI
V Raje, S Palekar, S Banella, K Patel
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022
12022
Formulation strategies for the development of high drug-loaded amorphous solid dispersions
H Mamidi, S Palekar, H Patel, PK Nukala, K Patel
Drug Discovery Today, 103806, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–16